QC Bioassay / Incoming & Components Analyst Location: Merseyside Contract: 6 Months Company: Global Biopharmaceutical Organisation Overview We are supporting a global biopharmaceutical organisation based in Liverpool in the search for an experienced QC Analyst to join their Quality Control team on a 6-month contract. This role will focus on the compliant execution of QC testing, inspection, and release activities across both bioassay and incoming materials/components, supporting critical vaccine manufacturing operations. You will also contribute to technical and validation studies, ensuring alignment with both departmental and site objectives. Key Responsibilities QC Bioassay * Perform QC testing on in-process, intermediate, and finished vaccine products * Conduct data review and interpretation in line with approved SOPs * Ensure all work is carried out in compliance with cGMP and regulatory standards * Accurately document all laboratory activities, ensuring data integrity * Support method validation, transfer, and technical studies QC Incoming & Components * Perform primary QC inspection and sampling of raw materials * Conduct testing of primary and secondary packaging components * Review and interpret analytical data in accordance with SOPs * Support the release of raw materials and components for manufacturing * Assist in deviations, investigations, and CAPA activities Requirements * Fluent in English (written and verbal) * Proven experience in QC testing techniques relevant to the role (bioassay and/or raw materials/components testing) * Strong experience working within a cGMP-regulated environment * Clear understanding of GMP compliance, documentation, and data integrity principles * Awareness of equipment qualification and method validation requirements * Understanding of root cause analysis and its application within investigations * Strong IT skills with experience using electronic laboratory and quality systems (e.g. LIMS, electronic documentation systems) * Demonstrable experience working within the pharmaceutical or biopharmaceutical industry under cGMP conditions